11/10/2001 Maghreb Confidential N°527

ALGERIA

SAIDAL
SAIDAL, an Algerian pharmaceuticals company, has pulled out of a joint venture launched in 1993 under the name Adaph in which it held a 10% interest alongside Fabre’s 45%% and Novo-Nordisk’s 45%. (...)   [79 words]   [€1,5]
Want to read more ? Please consider subscribing
or opening an electronic account to continue.
You already have an account
E-Mail
Password
Password reminder
Remember me
Create an account
E-Mail
Password
Confirm password
 
 


top of the page |  Home Page  |  Subscribe  |  About Us  |  Contacts  |  Legal Notices   |  Terms and Conditions  |  FAQ  |  French Version  | top of the page

Africa Intelligence | West Africa Newsletter | The Indian Ocean Newsletter | Maghreb Confidential |
Africa Energy Intelligence | Africa Mining Intelligence | Top African Leaders |
Africa Business Intelligence | African Government & Political News | Intelligence Online